Takashi Ogawa

Juntendo University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Keisuke Nakatome

Janssen Pharmaceuticals

JAPAN

View details

Shohei Fujita

Juntendo University

JAPAN

View details

Shigeki Aoki

Juntendo University Graduate School of Medicine

JAPAN

View details

Shiori Amemiya

Lecturer

University of Tokyo

JAPAN

View details

Haruka Takeshige-Amano

Juntendo University

JAPAN

View details

Taku Hatano

Associate Professor

Juntendo University

JAPAN

View details

Shinji Saiki

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Takashi Ogawa

Research Interests

Explore related searches

Contact this professor

Articles (16)

Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study

Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease

Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study

Antagonism of metabotropic glutamate receptor type 5 prevents levodopa‐induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence

Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson's disease

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan

Rigid real-time prospective motion-corrected three-dimensional multiparametric mapping of the human brain.

White matter microstructures in Parkinson's disease with and without impulse control behaviors

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)

White matter and nigral alterations in multiple system atrophy-parkinsonian type

Commentary: Progressive Encephalomyelitis with Rigidity and Myoclonus and Myasthenia Gravis Comorbid Status with Thymoma

Progressive Encephalomyelitis with Rigidity and Myoclonus and Myasthenia Gravis Comorbid Status with Thymoma

White matter alterations in Parkinson's disease with levodopa-induced dyskinesia

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease

Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson’s disease

Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases

Collaborators (7)

Keisuke Nakatome

Shohei Fujita

Shigeki Aoki

Shiori Amemiya

Haruka Takeshige-Amano

Taku Hatano

Shinji Saiki

Make your next move.